Financial Performance - In the first half of 2025, the company's operating revenue was 1.11 billion yuan, a decrease of 7.90% year-on-year [1] - The net profit attributable to shareholders was -103.54 million yuan, an improvement of 65.28% compared to the previous year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -202.58 million yuan, a year-on-year increase of 37.55% [1] - The basic earnings per share were -0.25 yuan [1] Profitability Metrics - The gross profit margin for the first half of 2025 was 52.85%, down by 10.31 percentage points year-on-year [2] - The net profit margin was -9.39%, an increase of 15.52 percentage points compared to the same period last year [2] Expense Management - The company's period expenses amounted to 732 million yuan, a reduction of 296 million yuan from the previous year [2] - The period expense ratio was 65.72%, down by 19.28 percentage points year-on-year [2] - Sales expenses decreased by 18.05%, management expenses decreased by 9.62%, R&D expenses decreased by 26.98%, and financial expenses decreased significantly by 3438.97% [2] Company Overview - The company, Shenzhen Huada Zhizao Technology Co., Ltd., was established on April 13, 2016, and listed on September 9, 2022 [5] - The main business focuses on life sciences and biotechnology, including the research, production, and sales of instruments, equipment, and related consumables [5]